CancerInfo Center

Determining When to Stop Cancer Screenings
There is considerable debate about the age when certain cancer screenings should begin. There may be even more debate about when cancer screenings should stop.
How Breast MRIs Are Being Used
Actress Christina Applegate, the daughter of a breast cancer survivor, had her first breast MRI (magnetic resonance imaging) in 2007. The next year she was diagnosed with breast cancer. Are more women following in Applegate’s footsteps?
The Aging of Childhood Cancer Survivors
An estimated 360,000 adults in the US are alive after winning against childhood cancer. About 250,000 of these adults are under the age of 40. A recently published study examined how childhood cancer survivors are aging.
Celebrity Cancer News May Have Powerful Impact
Earlier this week, Amy Robach, of Good Morning America , announced that doctors discovered she had breast cancer after an on-air mammogram she had as part of Breast Cancer Awareness Month.
Assessing Lymphedema in Breast Cancer Survivors
One of the long-term side effects of breast cancer treatment is a condition called lymphedema. It’s a swelling of the arm that not only affects appearance, but can also be painful and interfere with function.
Boosting Blood Cancer Survival
Lymphomas are blood cancers that start in the cells of the immune system. Burkitt’s lymphoma is a particularly aggressive form of the disease. New research may have discovered a better way to treat it.
Radiation Improved Breast Cancer Outlook
Ductal carcinoma in situ (DCIS) is the earliest form of breast cancer. Abnormal cells are found inside the milk duct of the breast. Unlike invasive breast cancers, ductal carcinoma in situ has not spread beyond the duct.
A Pancreatic Cancer Puzzle
Scientists have a mystery on their hands when it comes to pancreatic cancer trends. Trends are different among whites and blacks – but no one knows why.
New HER2+ Breast Cancer Treatment Recommendation
More than a quarter of women diagnosed with breast cancer have high levels of HER2, a protein that makes the cancer grow faster and more likely to return. New research has discovered one treatment method that’s been used may no longer be necessary.
New Rx for Blood Cancer Approved
Mantle cell lymphoma is a rare, but aggressive form of blood cancer. It’s a form of non-Hodgkin lymphoma. Patients with this disease got a new treatment option today.